Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Vaughan

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
The American Journal of Cardiology|September 1, 1990
Role of left ventricular dysfunction in selective neurohumoral activation in the recovery phase of anterior wall acute myocardial infarctionD E Vaughan, G A Lamas, M A Pfeffer
European Heart Journal|November 1, 1995
Role of the fibrinolytic system in preventing myocardial infarctionD E Vaughan, J L Rouleau, M A Pfeffer
Circulation|August 15, 1996
Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial functionC D Venkov, A B Rankin, D E Vaughan
Thrombosis and Haemostasis|March 1, 1997
Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykininN J Brown, J H Nadeau, D E Vaughan
Circulation|June 1, 1987
Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacyD E Vaughan, S Z Goldhaber, J Kim, et al.
Circulation|July 1, 1991
Streptokinase-induced platelet aggregation. Prevalence and mechanismD E Vaughan, E Van Houtte, P J Declerck, et al.
Kidney International|January 1, 1997
Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibitionT Oikawa, M Freeman, W Lo, et al.
American Heart Journal|August 1, 1988
Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolismS Z Goldhaber, D E Vaughan, S S Tumeh, et al.
The Journal of Biological Chemistry|June 15, 1992
Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activatorP J Declerck, M De Mol, D E Vaughan, et al.
The Journal of Clinical Investigation|August 1, 1989
Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbitsD E Vaughan, P J Declerck, M De Mol, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
The American Journal of Cardiology|September 1, 1990
Role of left ventricular dysfunction in selective neurohumoral activation in the recovery phase of anterior wall acute myocardial infarctionD E Vaughan, G A Lamas, M A Pfeffer
European Heart Journal|November 1, 1995
Role of the fibrinolytic system in preventing myocardial infarctionD E Vaughan, J L Rouleau, M A Pfeffer
Circulation|August 15, 1996
Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial functionC D Venkov, A B Rankin, D E Vaughan
Thrombosis and Haemostasis|March 1, 1997
Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykininN J Brown, J H Nadeau, D E Vaughan
Circulation|June 1, 1987
Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacyD E Vaughan, S Z Goldhaber, J Kim, et al.
Circulation|July 1, 1991
Streptokinase-induced platelet aggregation. Prevalence and mechanismD E Vaughan, E Van Houtte, P J Declerck, et al.
Kidney International|January 1, 1997
Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibitionT Oikawa, M Freeman, W Lo, et al.
American Heart Journal|August 1, 1988
Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolismS Z Goldhaber, D E Vaughan, S S Tumeh, et al.
The Journal of Biological Chemistry|June 15, 1992
Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activatorP J Declerck, M De Mol, D E Vaughan, et al.
The Journal of Clinical Investigation|August 1, 1989
Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbitsD E Vaughan, P J Declerck, M De Mol, et al.
Pageof 9